Clinical trial

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

NCT01746810

Study summary

ClinicalTrials.gov

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention Stereotactic body RT and IRGA Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-07-01

PhasePHASE1

Conditions

Recurrent Non-small Cell Lung Cancerunresolved

Interventions

Stereotactic body RT and IRGARADIATION

Sponsors & collaborators

New Mexico Cancer Research Alliancelead sponsor

Mapped research locations

AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01746810 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.